Maze Therapeutics (MAZE) Other Gross PP&E Adjustments (2024 - 2026)
Maze Therapeutics recorded quarterly Other Gross PP&E Adjustments of -$20.8 million in Q1 2026, down 697.13% quarter-over-quarter from $3.5 million in Q4 2025, and up 12.37% year-over-year from -$18.5 million in Q1 2025.
Maze Therapeutics' Other Gross PP&E Adjustments history runs 3 years deep, the most recent figure standing at -$20.8 million for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments rose 12.37% year-over-year to -$20.8 million; the TTM figure through Mar 2026 stood at -$20.8 million (up 12.37% YoY), while the FY2025 annual figure was $3.5 million, up 259.44% from the prior year.
- Other Gross PP&E Adjustments came in at -$20.8 million for Q1 2026 at Maze Therapeutics, down from $3.5 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.5 million in Q4 2025 to a low of -$23.7 million in Q1 2025.
- A 3-year average of -$14.6 million and a median of -$21.4 million in 2025 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments jumped 259.44% in 2025 and gained 12.37% in 2026, its largest moves.
- Maze Therapeutics' Other Gross PP&E Adjustments stood at -$2.2 million in 2024, then surged by 259.44% to $3.5 million in 2025, then plunged by 697.13% to -$20.8 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$20.8 million, $3.5 million, and -$22.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Maze Therapeutics | 1.37 Bn | 1.37 Bn | 18.21 Mn | -20.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.77 Mn |
| Mar 31, 2026 | -20.77 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Sep 30, 2025 | -22.04 Mn |
| Sep 30, 2025 | -22.04 Mn |
| Jun 30, 2025 | -22.55 Mn |
| Jun 30, 2025 | -22.55 Mn |
| Mar 31, 2025 | -23.71 Mn |
| Mar 31, 2025 | -23.71 Mn |
| Dec 31, 2024 | -2.18 Mn |
| Dec 31, 2024 | -2.18 Mn |